Who owns ASPIRE BIOPHARMA HLDGS INC WT EXP 021430?

Tip: Access positions for across all investors

Analyze quarterly positions in Aspire Biopharma Hldgs Inc Wt Exp 021430 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Aspire Biopharma Hldgs Inc Wt Exp 021430 stock

Who bought or sold ASPIRE BIOPHARMA HLDGS INC WT EXP 021430 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Adage Capital Partners GP 1.1M $21k 0% Jun 2026
 View chart
Saba Capital Management 984k $23k 0% Jun 2026
 View chart
Linden Advisors 900k $21k 0% Jun 2026
 View chart
Aristeia Capital 682k $16k 0% Jun 2026
 View chart
Toronto-Dominion Bank 516k $10k 0% Jun 2026
 View chart
OZ Management 500k $10k 0% Jun 2026
 View chart
Clear Street Group 331k $6.6k 0% Jun 2026
 View chart
Millennium Management 275k $5.5k 0% Jun 2026
 View chart
Highbridge Capital Management 273k $4.0k -48% Mar 2026
 View chart
D. E. Shaw & Co 200k $4.1k 0% Jun 2026
 View chart
Wolverine Asset Management 197k $3.9k 0% Jun 2026
 View chart
Verition Fund Management 191k $3.9k 0% Jun 2026
 View chart
Context Capital Management 175k $3.5k 0% Jun 2026
 View chart
Polar Securities 139k $3.2k 0% Jun 2026
 View chart
LMR Partners 125k $2.5k 0% Jun 2026
 View chart
Periscope Capital 125k $2.5k 0% Jun 2026
 View chart
Whitebox Advisors 119k $2.4k 0% Jun 2026
 View chart
Jpmorgan Chase & Co 100k $2.3k -63% Jun 2026
 View chart
Limestone Investment Advisors 75k $1.5k 0% Jun 2026
 View chart
Blue Owl Capital Holdings 50k $1.0k 0% Jun 2026
 View chart
Picton Mahoney Asset Management 50k $1.0k 0% Jun 2026
 View chart
Crossingbridge Advisors 50k $996.920000 0% Jun 2026
 View chart
Two Sigma Securities 41k $825.380000 100% Jun 2026
 View chart
OMERS Administration Corporation 25k $512.500000 0% Jun 2026
 View chart
Mint Tower Capital Management B.V. 25k $1.0k 0% Jun 2026
 View chart
Beacon Pointe Advisors 20k $400.000000 0% Jun 2026
 View chart
Flow Traders US 16k $0 3% Jun 2026
 View chart
Barclays 291.00 $5.994600 -97% Jun 2026
 View chart
Advisor Group Holdings 50.00 $1.000000 0% Jun 2026
 View chart
Investors Research Corp 10.00 $0 0% Jun 2026
 View chart

Who sold out of Aspire Biopharma Hldgs Inc Wt Exp 021430?

Fund or Company Name Date Sold Shares Held Valued At
VR Advisory Services Mar 2026 100k $1.7k
Athos Capital Mar 2026 21k $1.0k
Susquehanna International Mar 2026 17k $278.564600